Skip to main content
SpringerLink
Log in

Pfizer's amlodipine leads half-year prescriptions in Japanese market

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pfizer's amlodipine leads half-year prescriptions in Japanese market. Pharmacoecon. Outcomes News 462, 11 (2004). https://doi.org/10.2165/00151234-200404620-00027

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200404620-00027

Keywords

Search

Navigation